Skip to content

Drug interactions

Defibrotide + Tranexamic acid

Severity: Moderate

Defibrotide and Tranexamic acid: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tranexamic acid is an antifibrinolytic, while defibrotide is used for hepatic veno-occlusive disease and has profibrinolytic and antithrombotic activity. Given together, they have opposing effects on fibrinolysis, so each may blunt the other. Antifibrinolytic therapy may also raise thrombotic concern in patients being treated with defibrotide.

What this interaction means in plain words

Defibrotide and Tranexamic acid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Defibrotide belongs to Cardiovascular; Tranexamic acid belongs to Cardiovascular.

Evidence level: Low

Why it happens

Pharmacodynamic antagonism: tranexamic acid inhibits plasminogen activation and fibrinolysis, whereas defibrotide enhances fibrinolytic activity.

What to do

Avoid routine concurrent use unless the bleeding risk clearly warrants it. If both are needed, monitor for bleeding and for thrombosis and reassess the need for tranexamic acid frequently.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Defibrotide and Tranexamic acid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Defibrotide with Tranexamic acid?

MediHelp rates the interaction as moderate. Defibrotide and Tranexamic acid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tranexamic acid is an antifibrinolytic, while defibrotide is used for hepatic veno-occlusive disease and has profibrinolytic and antithrombotic activity. Given together, they have opposing effects on fibrinolysis, so each may blunt the other. Antifibrinolytic therapy may also raise thrombotic concern in patients being treated with defibrotide.

How serious is the interaction between Defibrotide and Tranexamic acid?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine concurrent use unless the bleeding risk clearly warrants it. If both are needed, monitor for bleeding and for thrombosis and reassess the need for tranexamic acid frequently.

What other medicines interact with Tranexamic acid?

MediHelp also lists interactions of Tranexamic acid with, for example, Dienogest / estradiol valerate, Ethinyl estradiol-drospirenone, Ethinyl estradiol-levonorgestrel. The full list is on the Tranexamic acid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in